MEANTI RAMONA

Costanzi, E., Grisetti, M., Bettucci, M., Meanti, R., Lonati, E., Morello, G., et al. (2025). Exploring the role of mesenchymal stem cell-derived extracellular vesicles in Alzheimer's disease: the impact of MSC preconditioning on targeted therapeutic efficacy. Intervento presentato a: ISEV2025 Annual Meeting, Vienna. Dettaglio

Meanti, R., Bresciani, E., Rizzi, L., Molteni, L., Coco, S., Omeljaniuk, R., et al. (2025). Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases. BIOMÉDECINE & PHARMACOTHÉRAPIE, 186(May 2025) [10.1016/j.biopha.2025.118044]. Dettaglio

Bassi, G., Giorgi, V., Lazzarin, M., Meanti, R., Omeljaniuk, R., Sarzi-Puttini, P., et al. (2025). Symptom management, adherence to therapy, and filling the gaps of medical cannabis therapy: a qualitative study on the importance of nursing consultations for fibromyalgia patients. JOURNAL OF CANNABIS RESEARCH, 7(1) [10.1186/s42238-025-00346-z]. Dettaglio

Mingardi, J., Meanti, R., Paoli, C., Cifani, C., Torsello, A., Popoli, M., et al. (2025). Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What Are the Connections?. CURRENT NEUROPHARMACOLOGY, 23(2), 172-186 [10.2174/1570159x22999240722095039]. Dettaglio

Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Omeljaniuk, R., et al. (2024). Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study. Intervento presentato a: 9th European Congress of Pharmacology (EPHAR 2024), Atene, Grecia. Dettaglio